INTRODUCTION
• Inherited Platelet Disorders are a heterogeneous group of rare diseases of variable severity.
• Some IPD are due to defects in genes that encode proteins that play critical roles in megakaryopoiesis and proplatelet production, leading to an inherited thrombocytopenia (IT).
• Alternatively, the molecular pathology may affect the development or maintenance of the platelet ultrastructure, the formation and cargo of granules, or platelet responses to agonists, which are known as Inherited Platelet Function Disorders (IPFDs). , VIPAS39; VPS33B, ANKRD26, GP1BA; GP1BB; GP9, GP6, MPL, PLA2G4A, NBEA, RUNX1, TBXAS1, ITGA2B; ITGB3, NBEAL2, GFI1B, AP3B1; AP3D1; BLOC1S3; BLOC1S6; DTNBP1; HPS1; HPS3; HPS4; HPS5; HPS6, FERMT3, ACTN1, FLNA, TUBB1, MYH9, RASGRP2, PLAU, HOXA11, ANO6, ABCA1, ABCG5; ABCG8, STIM1, THPO, RBM8A, TBXA2R, WAS, GATA1, GNAS, GNAQ, MASTL, MLPH, LYST, A2M, P2RX1, P2RY1, GP5, ITGA2, ADRA2A, VWF, F11 .
MLPA analysis will also be undertaken for MYH9, F11 and VWF. 
